SCHEMBL7706106

SCHEMBL7706106

Nc1ccc(-c2ccc3cc4ccc(-c5ccc(N)cc5)cc4cc3c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.59
CYP3A4 P08684 4/20 0.58
ALDH1A1 P00352 4/20 0.58
TDP1 Q9NUW8 3/20 0.58
TP53 P04637 1/20 0.58
PRKCZ Q05513 1/20 0.55
HSD17B10 Q99714 3/20 0.54
ALOX15 P16050 1/20 0.54
CASP1 P29466 1/20 0.54
CASP7 P55210 1/20 0.54
HBB P68871 1/20 0.54
HIF1A Q16665 1/20 0.54
TAAR1 Q96RJ0 2/20 0.48
ESR1 P03372 5/20 0.46
ESR2 Q92731 5/20 0.46
DHFR P00374 1/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
F2 P00734 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15481474 0.93 CYP3A4 (0.67) PLAUCYP3A4ALDH1A1TDP1TP53
SCHEMBL21537315 0.90 PLAU (0.59) PLAUCYP3A4ALDH1A1TDP1TP53
SCHEMBL6537114 0.85 CYP3A4 (0.65) PLAUCYP3A4ALDH1A1TDP1TP53
SCHEMBL29441264 0.85 CYP3A4 (0.65) PLAUCYP3A4ALDH1A1TDP1TP53
SCHEMBL28981808 0.85 CYP3A4 (0.65) PLAUCYP3A4ALDH1A1TDP1TP53
SCHEMBL23951341 0.85 HSD17B10 (0.71) PLAUCYP3A4ALDH1A1TDP1TP53
SCHEMBL28528867 0.85 CYP3A4 (0.65) PLAUCYP3A4ALDH1A1TDP1TP53
Benzidine SCHEMBL5570436 0.84 ALDH1A1 (0.68) PLAUCYP3A4ALDH1A1TDP1TP53
SCHEMBL23183328 0.81 CYP2A6 (0.56) PLAUCYP3A4ALDH1A1TDP1TP53
SCHEMBL25655779 0.78 CYP3A4 (0.50) PLAUCYP3A4ALDH1A1TDP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417178-B1 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits UNIVERSITY OF PITTSBURGH 2002-07-09 US disclosed
EP-1110945-A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition UNIVERSITY OF PITTSBURGH (US) 2001-06-27 EP disclosed
WO-1999024394-A9 COMPOUNDS FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION UNIV PITTSBURGH (US) 2001-05-31 WO disclosed
EP-1028941-A2 COMPOUNDS FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION UNIVERSITY OF PITTSBURGH (US) 2000-08-23 EP disclosed
WO-1999024394-A2 COMPOUNDS FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION UNIVERSITY OF PITTSBURGH (US) 1999-05-20 WO disclosed
EP-0823894-A1 AZOCOMPOUNDS FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION UNIVERSITY OF PITTSBURGH (US) 1998-02-18 EP disclosed
WO-1996034853-A1 AZOCOMPOUNDS FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION UNIVERSITY OF PITTSBURGH (US) 1996-11-07 WO disclosed